MedTrace Logo

Colorectal Cancer Screening in Xinxiang City

NCT06785714 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 25000

Last updated 2025-01-21

No results posted yet for this study

Summary

The primary objective of this study is to evaluate the sensitivity of the fecal protein dual-index test reagent for the detection of colorectal cancer (CRC).

Conditions

Sponsors & Collaborators

  • Xinxiang Municipal Health Commission

    collaborator UNKNOWN

  • Xinxiang Center for Disease Control and Prevention

    collaborator UNKNOWN

  • Xinxiang Central Hospital

    collaborator OTHER

  • The Affiliated People's Hospital of Xinxiang Medical University

    collaborator UNKNOWN

  • The Third Affiliated Hospital of Xinxiang Medical College

    collaborator UNKNOWN

  • Shanghai Jiao Tong University School of Medicine

    collaborator OTHER

  • The First Affiliated Hospital of Xinxiang Medical College

    lead OTHER

Eligibility

Min Age
45 Years
Max Age
74 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-09-01
Primary Completion
2025-01-15
Completion
2025-01-15

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06785714 on ClinicalTrials.gov